Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Why should I use sharewise

Agilent Technologies Inc. Stock

Price
Target price
€78.92

€78.92

1.120%
0.67
1.120%
€74.33

€74.33

 
Latest predictions
-
15.06.20
buy
-
31.05.20
buy
€125.00
10.12.19
buy
€81.00
18.06.19
buy
€67.65
16.01.19
buy
€64.94
09.09.18
buy
Your prediction

Agilent Technologies Inc. Stock

There is an upward development for Agilent Technologies Inc. compared to yesterday, with an increase of €0.67 (1.120%).
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Agilent Technologies Inc..
However, we have a potential of -6.234% for Agilent Technologies Inc. as the target price of €74.00 is below the current price of €78.92.

Comments

Published 10.12.19
Prediction Buy
Perf. (%) 6.114%
Target price 125.000
Change

Buy with target price 125.0

Show more
You may not comment on this article as you either did not confirm your account yet or were blocked. If you think this is a mistake please contact us. Show more

Other discussions about Agilent Technologies Inc. Stock

New thread

News

Agilent Technologies Announces Pricing of $500 Million of Senior Notes


Agilent Technologies, Inc. (NYSE: A) today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $500 million. The

Agilent Technologies Announces Proposed Offering of Senior Notes


Agilent Technologies Inc. (NYSE:A) today announced it is offering, subject to market and other conditions, a series of senior notes under an automatic shelf registration statement on file with the

Agilent to Present at Jefferies Virtual Healthcare Conference


Agilent Technologies Inc. (NYSE: A) today announced the following webcast for the investment community.



Jefferies Virtual Healthcare Conference
Wednesday, June 3, 2020 at 1:00 p.m. (ET)

Agilent Reports Second-Quarter Fiscal Year 2020 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.24 billion for the second quarter ended April 30, 2020, equal to revenue reported for the second quarter of 2019 and down 1.7% on a

Agilent Announces Cash Dividend of 18 Cents Per Share


Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 18 cents per share of common stock will be paid on July 22, 2020, to all shareholders of record as of the close of

Agilent PD-L1 Assay Receives FDA Approval for Use as a Companion Diagnostic


Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has approved the company’s PD-L1 IHC 28-8 pharmDx for expanded use in non-small cell lung cancer

Agilent Awards Trilogy Sciences with a Golden Ticket at LabCentral


Agilent Technologies Inc. (NYSE: A) announces that biotech startup Trilogy Sciences has been awarded an Agilent Golden Ticket at LabCentral, a leading biotech innovation hub based in Cambridge

Agilent Receives FDA Approval for PD-L1 Companion Diagnostic on Dako Omnis


Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has approved the company’s PD-L1 IHC 22C3 pharmDx as a companion diagnostic (CDx) to identify patients

Agilent Signs Sponsorship Agreement with My Green Lab


Agilent Technologies Inc. (NYSE: A) announced today that it has become a top-level sponsor of My Green Lab, a nonprofit organization dedicated to improving the sustainability of scientific

Agilent Technologies Provides Update on COVID-19 Impact; Sets Second-Quarter Earnings Call for May 21


Agilent Technologies, Inc. (NYSE: A) today announced that due to the expanded and evolving nature of the COVID-19 pandemic and resulting effects on customer operations, it is withdrawing its

Agilent Introduces New Handheld Raw Material ID System for Pharmaceutical Manufacturers


Agilent Technologies Inc. (NYSE: A) today announced the launch of the newest instrument in its Raman technology portfolio. The new Agilent Vaya Raman raw material identity verification system is a

Agilent Technologies to Change Location of Annual Meeting


Agilent Technologies, Inc. (NYSE: A) today filed a supplement to its proxy statement with the Securities and Exchange Commission announcing a change of location for its previously adjourned annual

Agilent Announces New Class 1 Triple Quadrupole LC/MS System


Agilent Technologies Inc. (NYSE: A) today introduced the Agilent K6460S Clinical Edition TQ LC/MS system, designed to improve in vitro diagnostic workflows in clinical labs.



Agilent’s

Agilent Technologies Announces Cash Dividend of 18 Cents Per Share


Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 18 cents per share of common stock will be paid on April 22, 2020, to all shareholders of record as of the close of

Agilent Technologies to Adjourn Annual Meeting Until April 17, 2020


Agilent Technologies, Inc. (NYSE: A) today announced plans to adjourn its annual meeting of stockholders, originally scheduled to be held March 18, 2020, due to public health considerations

Agilent Introduces CrossLab Connect Services for Lab-wide Asset Monitoring


Agilent Technologies Inc. (NYSE: A) announced today an extension to its digital lab capabilities with Agilent CrossLab Asset Monitoring, an advanced service for laboratories seeking increased

Agilent Receives Two Scientists’ Choice Awards


Agilent Technologies Inc. (NYSE: A) today announced that two of the company’s instruments have received Scientists’ Choice awards. The Agilent 8890 GC system won for Best New Separations Product

Agilent Introduces Three New Microarrays for Prenatal and Postnatal Research


Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.



The new Agilent

Agilent and Visiopharm Co-promote Advanced Digital Precision Pathology Solutions


Agilent Technologies Inc. (NYSE: A) and Visiopharm today announced that they have entered a co-marketing agreement. The announcement is happening at the USCAP 109th Annual Meeting being held

Agilent Technologies Announces Webcasts for Investment Community


Agilent Technologies Inc. (NYSE: A) today announced the following webcasts for the investment community.



40th Annual Cowen And Company Healthcare Conference
Tuesday, March 3, 2020 at 10:00 a.m

Agilent Technologies Reports First Quarter Fiscal Year 2020 Financial Results


Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.36 billion for the first quarter ended Jan. 31, 2020, up 5.7% year over year (and up 2.4% on a core(1) basis).



On a GAAP basis

Agilent Technologies Announces Twist Bioscience Agrees to Pay $22.5 Million Settlement in IP Litigation


Agilent Technologies Inc. (NYSE: A) today announced it has reached an agreement with Twist Bioscience under which Twist has agreed to pay Agilent a sum of $22.5 million to settle Agilent’s claims

Agilent Teams with Indian Institute of Technology Delhi to Enhance Biotherapeutics


Agilent Technologies Inc. (NYSE: A) today announced that it is joining forces with the Indian Institute of Technology Delhi (IIT Delhi) to promote biopharmaceutical research.



Agilent and IIT

Agilent Technologies to Webcast First Quarter Fiscal Year 2020 Financial Results Conference Call


Agilent Technologies, Inc. (NYSE: A) will release first-quarter fiscal year 2020 financial results after the stock market closes on Feb. 18. The company will also host a live webcast of its